Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. ARS Other Annual Report to Security Holders
  3. DEFA14A Proxy Proxy Materials
  4. 8-A12B Other Registration of Securities
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. DEFA14A Proxy Proxy Materials
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. EFFECT Other Notice of Effectiveness
  9. POS EX Other Post-effective Amendment
  10. DEFA14A Proxy Proxy Materials
  11. POS AM Other Post-effective Amendment for Registration Statement
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. POSASR Other POSASR
  14. DEFA14A Proxy Proxy Materials
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. S-3ASR Offering Registration Statement
  17. DEFA14A Proxy Proxy Materials
  18. EFFECT Other Notice of Effectiveness
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 2 of 3 · 47 filings